FOXP3 and fatty liver disease: Simultaneous blocking of CD25 or IL-17A and IL-17F shifted the TH17/Foxp3+ TREG imbalance from MCD diet-induced TH17 dominance to Foxp3+ TREG dominance and also decreased hepatic steatosis and inflammation [73].